USFDA completes inspection at Dishman Carbogen Amcis’ facility in Naroda

16 Jun 2025 Evaluate

United States Food and Drug Administration (USFDA) has successfully completed inspection at Dishman Carbogen Amcis’ facility in Naroda, Ahmedabad on June 12, 2025. The inspection was planned between June 9, 2025 to June 13, 2025. 

The inspection was concluded without any observation or issuance of form 483’s, confirming that no concerns were discovered during the inspection. Thus, the company’s facilities at Naroda and Bavla in India, and multiple group facilities in Switzerland and the Netherlands continue to be approved by the USFDA.

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.


Dishman Carbogen Amc Share Price

223.15 -5.45 (-2.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×